Type 2 diabetes remission through intensive lifestyle changes

Remission of Type 2 Diabetes With Mediterranean Diet, Physical Activity and Psychological Support: a Randomized Clinical Trial

NA · University of Split, School of Medicine · NCT07017127

This trial tests whether an intensive lifestyle program—Mediterranean diet with a calorie deficit, daily physical activity, stress-resilience coaching, and group support—can put people with recent type 2 diabetes into remission without diabetes medications.

Quick facts

PhaseNA
Study typeInterventional
Enrollment120 (estimated)
Ages20 Years to 69 Years
SexAll
SponsorUniversity of Split, School of Medicine (other)
Locations1 site (Split)
Trial IDNCT07017127 on ClinicalTrials.gov

What this trial studies

This randomized interventional trial compares an intensive lifestyle program to usual clinical care in adults with type 2 diabetes. The intervention combines a calorie-restricted Mediterranean diet, daily physical activity, psychosocial stress-resilience training, and regular group support sessions. Primary outcomes include diabetes remission defined as HbA1c <6.5% off medications and substantial weight loss (>15 kg), with monitoring for any adverse effects. Eligible participants are typically those diagnosed within the past seven years with BMI 27–45 kg/m² and not using insulin.

Who should consider this trial

Good fit: Adults with type 2 diabetes diagnosed within the last seven years, BMI 27–45 kg/m², not on insulin, and able to participate in regular exercise and group sessions are ideal candidates.

Not a fit: People with long-standing or insulin-treated diabetes, severe heart or kidney disease, mobility restrictions, recent major illness, or certain psychiatric conditions are unlikely to benefit or may be excluded.

Why it matters

Potential benefit: If successful, the program could allow some people to stop diabetes medications by achieving normal blood sugar levels and significant weight loss, lowering their risk of long-term complications.

How similar studies have performed: Previous intensive weight-loss programs have produced remission in many people with recent-onset type 2 diabetes, so this approach builds on existing evidence though the exact combination of Mediterranean diet, stress resilience training, and group support is less commonly tested together.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* type 2 diabetes diagnosis
* incident cases or diagnosed not more than 7 years ago
* body mass index of 27-45 kg/m²

Exclusion Criteria:

* mobility restriction
* use of mobility aids
* insulin therapy
* HbA1c \>12%
* TSH \>10 mU/L
* heart failure (NYHA III, NYHA IV)
* use of obesity pharmacotherapy (orlistat, GLP-1 receptor agonists, GLP-1/GIP dual agonists) for less than 6 months
* weight loss greater than 5 kg in the last 6 months
* chronic kidney disease and estimated glomerular filtration rate \<30 ml/min/1.73 m2
* active treatment of proliferative diabetic retinopathy with anti-VEGF
* heart attack or stroke in the past 1 year
* active malignant disease diagnosed in the past 1 year
* eating disorders
* pregnancy or pregnancy planning
* substance abuse
* learning disabilities
* acute episode of severe depression
* current use of antipsychotics
* food allergy

Where this trial is running

Split

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Diabetes Mellitus Type 2, Obese Diabetics, diabetes remission, Mediterranean diet, physical activity, stress, weight loss, healthy lifestyle

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.